DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,046 filers reported holding DANAHER CORPORATION in Q3 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $752,326,000 | -11.7% | 2,564,778 | -1.0% | 0.40% | -9.2% |
| Q4 2021 | $851,983,000 | +10.1% | 2,589,535 | +1.9% | 0.44% | -0.9% |
| Q3 2021 | $773,702,000 | +15.4% | 2,541,395 | +1.7% | 0.44% | +17.0% |
| Q2 2021 | $670,392,000 | +24.0% | 2,498,105 | +4.0% | 0.38% | +21.3% |
| Q1 2021 | $540,653,000 | +2.8% | 2,402,049 | +1.5% | 0.31% | -5.5% |
| Q4 2020 | $525,825,000 | +3.5% | 2,367,086 | +0.3% | 0.33% | -10.1% |
| Q3 2020 | $507,991,000 | +22.5% | 2,359,127 | +0.6% | 0.36% | +14.8% |
| Q2 2020 | $414,593,000 | +32.3% | 2,344,584 | +3.6% | 0.32% | +10.8% |
| Q1 2020 | $313,354,000 | -10.2% | 2,263,958 | -0.4% | 0.29% | +12.5% |
| Q4 2019 | $348,927,000 | +7.1% | 2,273,436 | +0.8% | 0.26% | -3.0% |
| Q3 2019 | $325,734,000 | +3.9% | 2,255,304 | +2.8% | 0.26% | +1.5% |
| Q2 2019 | $313,408,000 | +13.0% | 2,192,889 | +4.4% | 0.26% | +7.9% |
| Q1 2019 | $277,419,000 | +39.8% | 2,101,339 | +9.2% | 0.24% | +21.8% |
| Q4 2018 | $198,382,000 | -1.2% | 1,923,798 | +4.1% | 0.20% | +11.9% |
| Q3 2018 | $200,806,000 | +13.1% | 1,848,024 | +2.7% | 0.18% | +4.8% |
| Q2 2018 | $177,574,000 | +3.6% | 1,799,492 | +2.8% | 0.17% | -0.6% |
| Q1 2018 | $171,421,000 | +10.3% | 1,750,806 | +4.5% | 0.17% | +9.0% |
| Q4 2017 | $155,478,000 | +12.4% | 1,675,046 | +3.9% | 0.16% | +3.3% |
| Q3 2017 | $138,313,000 | +8.0% | 1,612,412 | +6.2% | 0.15% | -2.0% |
| Q2 2017 | $128,110,000 | +18.5% | 1,518,068 | +20.1% | 0.15% | -7.3% |
| Q1 2017 | $108,114,000 | -1.1% | 1,264,048 | -10.0% | 0.16% | +8.6% |
| Q4 2016 | $109,314,000 | +4.3% | 1,404,347 | +5.1% | 0.15% | -3.2% |
| Q3 2016 | $104,767,000 | -20.2% | 1,336,479 | +2.8% | 0.16% | -24.2% |
| Q2 2016 | $131,285,000 | +3.5% | 1,299,853 | -2.8% | 0.21% | +1.0% |
| Q1 2016 | $126,854,000 | +0.3% | 1,337,274 | -1.8% | 0.20% | -5.1% |
| Q4 2015 | $126,467,000 | +13.8% | 1,361,621 | +4.4% | 0.22% | -0.5% |
| Q3 2015 | $111,132,000 | +6.7% | 1,304,213 | +7.2% | 0.22% | +6.9% |
| Q2 2015 | $104,159,000 | +4.9% | 1,216,952 | +4.0% | 0.20% | +1.5% |
| Q1 2015 | $99,304,000 | +5.6% | 1,169,656 | +6.7% | 0.20% | +1.0% |
| Q4 2014 | $93,997,000 | +16.1% | 1,096,681 | +2.9% | 0.20% | +10.6% |
| Q3 2014 | $80,963,000 | -5.1% | 1,065,587 | -1.7% | 0.18% | -6.8% |
| Q2 2014 | $85,323,000 | +5.7% | 1,083,740 | +0.7% | 0.19% | +0.5% |
| Q1 2014 | $80,738,000 | -0.1% | 1,076,508 | +2.8% | 0.19% | -2.6% |
| Q4 2013 | $80,852,000 | +12.6% | 1,047,302 | +1.1% | 0.20% | +0.5% |
| Q3 2013 | $71,803,000 | +13.1% | 1,035,823 | +3.3% | 0.20% | +5.4% |
| Q2 2013 | $63,472,000 | – | 1,002,716 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |